Circulating Levels of Human salusin-β,a Potent Hemodynamic and Atherogenesis Regulator-Reference-Cited by-同舟云学术

Circulating Levels of Human salusin-β,a Potent Hemodynamic and Atherogenesis Regulator

Published:2013-10-03 Issue:10 Volume:8 Page:e76714
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Fujimoto Kazumi,Hayashi Akinori,Kamata Yuji,Ogawa Akifumi,Watanabe Takuya,Ichikawa Raishi,Iso Yoshitaka,Koba Shinji,Kobayashi Youichi,Koyama Takatoshi,Shichiri Masayoshi

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference21 articles.

1. Coexistence of salusin and vasopressin in the rat hypothalamo-hypophyseal system;F Takenoya;Neurosci Lett,2005

2. Systemic distribution of salusin expression in the rat;N Suzuki;Hypertens Res,2007

3. Chronic osmotic stimuli increase salusin-β-like immunoreactivity in the rat hypothalamo-neurohypophyseal system: possible involvement of salusin-β on [Ca²⁺]_i increase and neurohypophyseal hormone release from the axon terminals;T Saito;J Neuroendocrinol,2008

4. Distinct systemic distribution of salusin-α and salusin-β in the rat;N Suzuki;Peptides,2011

5. Salusins: newly identified bioactive peptides with hemodynamic and mitogenic activities;M Shichiri;Nat Med,2003

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum salusin-α and -β levels in patients with parkinson’s disease;Neurological Sciences;2023-09-05

2. Use of salusin β for predicting atherosclerosis and components of the metabolic syndrome;Advances in Clinical and Experimental Medicine;2023-06-30

3. Upregulated expression of a TOR2A gene product‐salusin‐β in the paraventricular nucleus enhances sympathetic activity and cardiac sympathetic afferent reflex in rats with chronic heart failure induced by coronary artery ligation;Acta Physiologica;2023-05-31

4. Serum salusin-β levels in patients with systemic lupus erythematosus;Clinical Rheumatology;2023-04-29

5. Saluisn-β contributes to endothelial dysfunction in monocrotaline-induced pulmonary arterial hypertensive rats;Biomedicine & Pharmacotherapy;2022-11